Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02090517

Laser Therapy Versus Electrosurgery For Nasal Telangiectasias

Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the efficacy of various treatment options for eliminating nasal telangiectasias. The study will compare the outcome of treating nasal telangiectasias with the following; no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery.

Conditions

Interventions

TypeNameDescription
DEVICEPulsed Dye LaserPulsed dye laser treatments will be performed with a 595 nanometer wavelength, 20 millisecond pulse duration, at 10 Joules/cm2, with a 10 millimeter spot size.
DEVICELong Pulsed Alexandrite LaserAlexandrite laser will be used with a 755 nanometer wavelength, 40 millisecond pulse duration, at 88Joules/cm2, with a 6 millimeter spot size.
DEVICEPulsed Dye Laser Plus Nd:YAG LaserThe Cynergy with MultiPlex will be used with a multiplex mode system with a pulse dye laser at 585 nanometer wavelength, 20 milliseconds pulse duration, at 7 Joules/cm2 with a 7 millimeter spot size, with a short delay, followed by a Nd:YAG 1064 nanometer wavelength, 20 millisecond pulse duration, at 50 Joules/cm2 with a 7 millimeter spot size.
PROCEDUREElectrodesiccationA curette is used to scrape off the cancer down to the dermis. The scraping is then paused while an electrosurgical device like a hyfrecator is used next. Electrodesiccation is performed over the raw surgical ulcer to denature a layer of the dermis and the curette is used again over the surgical ulcer to remove denatured dermis down to living tissue.

Timeline

Start date
2014-06-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2014-03-18
Last updated
2017-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02090517. Inclusion in this directory is not an endorsement.